Analyst consensus rating
Revolution Medicines Analyst Rating: Strong Buy
RVMD is rated Strong Buy by 21 analysts with a $247.11 target. As of 2026-09-02.
Direct answer
Revolution Medicines's consensus rating is Strong Buy.
21 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $247.11.
Forecast evidence checked September 2, 2026.
Get free Revolution Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $209.37
- Average price target
- $247.11
- High price target
- $320.00
- Low price target
- $179.00
- Low target gap
- -14.5%
- Target upside
- +18%
- High target gap
- +52.8%
- Target range width
- 67.3%
- Consensus rating
- Strong Buy
- Analysts
- 21
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Revolution Medicines?
Revolution Medicines has a verified Strong Buy consensus. The same dataset has an average price target of $247.11.
How far are Revolution Medicines's low and high targets from the recorded price?
The low target implies -14.5%, while the high target implies +52.8%.
How many analysts are included in Revolution Medicines's consensus?
The verified consensus includes 21 analysts.
How is Revolution Medicines's target upside or downside calculated?
The average target of $247.11 is divided by the recorded price of $209.37, then one is subtracted to produce +18%. This does not guarantee a future return.
When was Revolution Medicines's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.